Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2022
   Trial
2. Prognostic Role of Prior Heart Failure Hospitalization Among Patients Hospitalized for Worsening Chronic Heart Failure.Circulation. Heart failure · 2021
   Trial
3. Developing Clinical Risk Prediction Models for Worsening Heart Failure Events and Death by Left Ventricular Ejection Fraction.Journal of the American Heart Association · 2023
   Article
4. Importance of diagnostic setting in determining mortality in patients with new-onset heart failure: temporal trends in Denmark from 1997 to 2017.European heart journal. Quality of care & clinical outcomes · 2022
   Article
5. Analysis of Worsening Heart Failure Events in an Integrated Health Care System.Journal of the American College of Cardiology · 2022
   Article
6. Initiation and long-term use of tolvaptan for patients with worsening heart failure through hospital and clinic cooperation.Nagoya journal of medical science · 2021
   Article
7. Heart failure in the last year: progress and perspective.ESC heart failure · 2020
   Review
8. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial.JACC. Heart failure · 2020
   Article
9. Recognizing the Significance of Outpatient Worsening Heart Failure.Journal of the American Heart Association · 2020
   Article
10. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.Circulation · 2019
    Review

Corrections and comments

• Comment on
  Heart failure in the outpatient versus inpatient setting: findings from the BIOSTAT-CHF study.2019

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as